期刊文献+

结核病患者全基因组甲基化与抗结核药致肝损伤关系的研究

A STUDY OF THE RELATIONSHIP BETWEEN TB PATIENTS'WHOLE-GENOME DNA METHYLATION AND ANTITUBERCULOSIS DRUG-INDUCCED LIVER INJURY
原文传递
导出
摘要 目的探讨结核病患者血浆中全基因组甲基化与抗结核药物性肝损伤(ADLI)的相关性。方法采用1∶1匹配的病例对照研究设计。接受抗结核化疗6个月内发生ADLI者160例为病例,选择与病例同居住地、年龄相差<5岁、同期未发生ADLI的结核病患者160例为对照。收集研究对象的相关信息,采集EDTA抗凝血液标本。磁珠法提取血清游离DNA,高效液相色谱法检测全基因组的甲基化水平。SPSS17.0软件用于统计学分析。结果与对照比较,既往病史、饮酒的差异均具有统计学意义(P<0.05),与ADLI的发生有关。而文化程度、婚姻、居住地、吸烟、职业的差异均无统计学意义(P>0.05)。病例和对照甲基化水平分别为(1.48±0.52)%和(8.75±1.94)%,差异有统计学意义,病例甲基化水平较低(P<0.05)。结论全基因组甲基化对ADLI的发生有明显影响,低甲基化水平的患者更易发生ADLI。 Objective To explore the correlation of whole-genome DNA methylation and antituberculosis drug-inducced liver injury in TB patients.Methods A one to one matched case control study was employed.Totally 160 cases were selected as the study cases,who accepted the anti-TB chemotherapy within six months and occurred ADLI;Based on cohabitation residence,age difference of〈5 years old,by the same anti-TB chemotherapy within six months,another 160 cases of TB patients were as controls,who did not occur ADLI.The relative factors and blood samples of each subject were collected.Serum DNA was extracted using the magnetic bead,and genome-wide methylation levels were detected by high performance liquid chromatography.SPSS17.0statistical analysis system software was employed.Results Compared with the control,history and drinking differences were statistically significant(P〈0.05),they were the risk factors of ADLI,but education,marriage,residence,smoking,occupation were no significant difference(P〉0.05).The whole-genome methylation level[(1.48±0.52)% vs(8.75±1.94)%]of the two groups was of statistically significant difference,the methylated of the case group was at a lower level(P〈0.05).Conclusion The genome-wide methylation impacts the occurrence of ADLI,low methylation levels are more likely to ADLI and it is a risk factor of ADLI.
机构地区 华北理工大学
出处 《中国煤炭工业医学杂志》 2015年第12期1964-1967,共4页 Chinese Journal of Coal Industry Medicine
基金 国家自然科学基金资助项目(编号:81041096)
关键词 肺结核 抗结核药致肝损伤 DNA甲基化 Pulmonary tuberculosis Antituberculosis drug-inducced liver injury DNA methylation
  • 相关文献

参考文献15

  • 1Forget EJ, Menzies D. Adverse reactions to first- line antituberculosis drugs ~-J]. Expert Opin Drug Saf, 2006,5(2) :231 - 249.
  • 2Malcolm A,Steele MD. Toxic hepatitis with isoniazid and rifampin- a meta- analysis[J]. Chest, 1999,2: 465 - 471.
  • 3Ohkawa K, Hashiguchi M,Ohno K, et al. Risk factors for antituberculous chemotherapy- induced hepato- toxicity in Japanese pediatric patients[J]. Clin Phar- macol Ther, 2002,72 : 220 - 226.
  • 4McNeill L, Allen M, Estrada C, et al. Pyrazinamide and rifampin vs isoniazid for the treatment of latent tubercu- losis~improved completion rates but more hepatotoxicity [J]. Chest,2003,123 ~ 102 - 106.
  • 5Jasmer RM, Saukkonen JJ, Blumberg HM. Short- course rifampin and pyrazinamide compared with iso- niazid for latent tuberculosis infection., a multicenter clinical trialI-J]. ANN intern MED, 2002,137 : 640 - 647.
  • 6夏愔愔,詹思延.国内抗结核药物不良反应发生率的综合分析[J].中华结核和呼吸杂志,2007,30(6):419-423. 被引量:208
  • 7WuCT, MorrisJ R. Genes, genetics and epigenetic Cor- respondence[J]. Science,2001,293 : 1103 - 1105.
  • 8Monk M. Epigenetic programming of differential gene expression in development and evolution[J]. Dev Genet, 1995,17(3) :188- 197.
  • 9Wang WM, Wu PC ~ Yuen MF, et al. Antituberculosis drug- related liver dysfunction in chronic hepatitis t3 infection[J]. Hepatology, 2000,31 : 201 - 206.
  • 10杨柳明,徐克成,赵延龙,吴志荣,陈杜芳,岑卓英,徐克成,左建生,危北海.肝活检对转氨酶正常的慢性乙型肝炎感染的临床意义[J].中华消化杂志,2001,21(10):590-592. 被引量:30

二级参考文献13

  • 1Hussain Z, Kar P, Husain SA. Antituberculosis drug-induced hepatitis: risk factors, prevention and management. Indian J Exp Biol,2003,41 : 1226-1232.
  • 2Onnerod LP, Horsfleld N. Frequency and type of reactions to antituberculosis drugs: observations in routine treatment. Tuber Lung Dis, 1996,77:37-42.
  • 3Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology, 1997,26,664-669.
  • 4Danan G, Benichou C, Flahault A. Score of suspected drug-induced acute liver disorders. Presentation of an evaluation sheet. Gastroenterol Clin Biol, 1993,17 ( 5 pt 2 ) : H22-H24.
  • 5Iwasa M ,Zeniya M,Kumagi T,et al. Modified diagnostic criteria of drug-induced liver injury proposed by the intemational consensus meeting, Hepatogastroenteroloty,2005,52:869-874.
  • 6Durand F, Jebrak G, Pessayre D, et al. Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status. Drug Saf, 1996,15 : 394-405.
  • 7Ungo JR, Jones D, Ashkin D, et al. Antituberculosis drug-inducted hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. AM J Respir Crit Care Med, 1998,157(6 Pt 1 ):1871-1876.
  • 8Tost JR,Vidal R, Cayla J,et al. Severe hepatotoxicity due to anti- tuberculosis drugs in Spain. Int J Tuberc Lung Dis,2005,9:534- 540.
  • 9WHO's Certified [ DB/OL]. WHO Stop TB Department: Global tuberculosis control: surveillance, planning, financing, WHO report 2007 [ 2007-05-10 ]. http://whqlibdoc. who. int/ publications/2007/9789241563141_eng.pdf.
  • 10徐克成,危北海,姚希贤,张万岱,陈泽民,陈治水,李道本.慢性乙型肝炎的现代治疗[J].胃肠病学和肝病学杂志,1999,8(4):301-308. 被引量:22

共引文献236

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部